Translational Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.9 | Q2 | 73.6% | 1.383 | Q1 | 90.7% |
| 2024 | 4.1 | Q2 | 72.4% | 1.408 | Q1 | 91.3% |
| 2023 | 4.5 | Q1 | 73.0% | 1.263 | Q1 | 90.2% |
| 2022 | 5.0 | Q2 | 70.9% | 1.150 | Q1 | 89.2% |
| 2021 | 4.8 | Q2 | 63.9% | 1.060 | Q2 | 87.7% |
| 2020 | — | — | 1.343 | Q2 | 90.9% | |
| 2019 | — | — | 1.267 | Q2 | 90.1% | |
| 2018 | — | — | 1.172 | Q2 | 87.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1936-5233
ISSN
1944-7124
country
UScoverage
2008-2026